Daniel Fologea

Title: The Innovative Contributions of Daniel Fologea

Introduction

Daniel Fologea is a notable inventor based in Boise, ID (US), recognized for his significant contributions to the field of pharmaceutical delivery systems. With a total of 4 patents, Fologea has developed innovative technologies that enhance the efficacy of drug delivery through the use of liposomes triggered by radiation.

Latest Patents

Fologea's latest patents include groundbreaking work on radiation-triggered liposomes. This technology focuses on liposomes that contain cholesterol and sphingolipids modified to include reactive groups. These groups are activated by ionizing radiation, leading to crosslinking with other lipids within the liposome, which facilitates the release of pharmaceutical contents. Another significant patent involves methods and compositions for X-ray induced release from pH-sensitive liposomes. This invention describes lipid vesicles that release an agent after exposure to ionizing radiation, allowing for controlled release based on timing and localization of radiation exposure.

Career Highlights

Throughout his career, Daniel Fologea has worked with esteemed institutions such as the University of Arkansas and Boise State University. His work has significantly advanced the understanding and application of liposomal drug delivery systems, making him a key figure in this innovative field.

Collaborations

Fologea has collaborated with notable colleagues, including Ralph L. Henry and Greg J. Salamo, contributing to the advancement of research in pharmaceutical technologies.

Conclusion

Daniel Fologea's innovative work in radiation-triggered liposomes and pH-sensitive drug delivery systems showcases his commitment to enhancing pharmaceutical applications. His contributions continue to influence the field and pave the way for future advancements in drug delivery technologies.